Back

Notification report


Full notification file


General information

Notification Number
B/DE/17/PEI3148

Member State to which the notification was sent
Germany

Date of acknowledgement from the Member State Competent Authority
25/07/2017

Title of the Project
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SDF.CD19.CD28.4-1BBzeta retroviral vector – a unicenter Phase I/II clinical trial (HD-CAR-1)

Proposed period of release:
01/07/2018 to 03/06/2020

Name of the Institute(s) or Company(ies)
Universitätsklinikum Heidelberg, ;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
Other: mammal

Identity of the GMO:
Mammals: human T lymphocytes

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HumanHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
12/04/2018 00:00:00
Remarks: